FINWIRES · TerminalLIVE
FINWIRES

Racura Oncology Doses First Patient in Phase 1 Trial of Lung Cancer Drug Candidate

By

Racura Oncology (ASX:RAC) dosed the first patient in a phase 1 clinical trial evaluating its RC220 drug candidate in combination with osimertinib for the treatment of non-small cell lung cancer, according to a Thursday filing with the Australian bourse.

The company said no adverse events were seen during or after the first RC220 infusion.

The study is using single-patient cohorts for the first three dose escalation stages before advancing to larger cohorts to determine the maximum tolerated dose. Additional clinical trial sites are expected to open in the coming months.

Related Articles

Asia

Market Chatter: Toyota to Reduce Overseas Output Amid Hormuz Closure

Toyota Motor (TYO:7203) will slash production outside Japan by about 100,000 units by around February 2027 as the de facto closure of the Strait of Hormuz affects demand overseas, Nikkei Asia reported Wednesday.The automotive giant will also slash electric vehicle production for China, the report said.Toyota did not immediately respond to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

TYO:7203
Asia

Update: Comet Ridge Secures Commitments for AU$40 million Placement; Shares Hit Five-Year Low

(Updates with the stock movement in the headline and last paragraph.)Comet Ridge (ASX:COI) received firm commitments for a two-tranche placement of new shares to existing and new investors to raise AU$40 million, according to a Wednesday Australian bourse filing.It plans to issue 390.2 million fully paid ordinary shares at an issue price of AU$0.1025 per share. The first tranche seeks to raise around AU$30.6 million utilising the company's capacity, while the second tranche seeks to raise around AU$9.4 million, subject to shareholder approval.It also plans to offer eligible shareholders the opportunity to participate via a share purchase plan to raise up to an additional AU$5 million.Comet Ridge shares declined nearly 22% in recent Wednesday trade and earlier hit their lowest level since July 2021.

ASX:COI
Asia

Gentrack Group Completes Dubai Technology Partners Acquisition

Gentrack Group (ASX:GTK, NZE:GTK) completed its acquisition of airport technology and services provider Dubai Technology Partners, according to a Wednesday filing with the Australian bourse.Dubai Technology Partners has around 60 employees and will be integrated into Gentrack's Veovo airports division, the company said.

ASX:GTKNZE:GTK